AL
EBS icon

Airain Ltd’s Emergent Biosolutions EBS Stock Holding History

Airain Ltd’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$648K Buy
19,118
+3,257
+21% +$101K 0.03% 489
2017
Q1 		$461K Buy
+15,861
New +$483K 0.02% 513
2016
Q4 		– Sell
-13,829
Closed -$436K – 712
2016
Q3 		$436K Buy
+13,829
New +$402K 0.03% 453
2015
Q4 		– Sell
-11,256
Closed -$321K – 889
2015
Q3 		$321K Sell
11,256
-883
-7% -$29.1K 0.02% 591
2015
Q2 		$400K Buy
+12,139
New +$376K 0.02% 577
2014
Q3 		– Sell
-12,951
Closed -$291K – 829
2014
Q2 		$291K Sell
12,951
-1,183
-8% -$27.6K 0.02% 555
2014
Q1 		$357K Buy
+14,134
New +$357K 0.06% 434

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Airain Ltd's EBS Position: Q2 2017 in Review

Airain Ltd increased its Emergent Biosolutions (EBS) stake by 21% in Q2 2017, buying an estimated $101K and bringing the position to 19,118 shares worth $648K. The position accounts for 0.03% of the portfolio, ranked #489.

Airain Ltd first reported a position in EBS in Q1 2014 and has held it in 7 quarters since. 181 funds tracked by Wall St. Rank hold EBS as of Q2 2017.

  • Airain Ltd held 19,118 shares of Emergent Biosolutions worth $648K as of Q2 2017.
  • Airain Ltd bought 3,257 Emergent Biosolutions shares in Q2 2017, an estimated $101K.
  • Emergent Biosolutions made up 0.03% of Airain Ltd's portfolio in Q2 2017, its #489 holding.
  • Airain Ltd first reported a position in Emergent Biosolutions in Q1 2014 and has held it in 7 quarters since.
  • 181 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.